-
EP1573027
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1573027
| EP1573027 - METHOD OF REDUCING ANGIOGENESIS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.12.2007 Database last updated on 02.11.2024 | Most recent event Tooltip | 28.12.2007 | Application deemed to be withdrawn | published on 30.01.2008 [2008/05] | Applicant(s) | For all designated states Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston, MA 02215 / US | [2005/37] | Inventor(s) | 01 /
ROBSON, Simon, C. 250 Glen Road Weston, MA 02493 / US | 02 /
GÖPFERT, Christian Hummelsbütteler Kirchenweg 121 22339 Hamburg / DE | 03 /
SUNDBERG, Christian Luthagsesplanaden 36A 75234 Uppsala / SE | 04 /
HOSHI, Tomokazu 2-6-5-13-602 Kagura, Asahikawa Hokkaido 078-8510 / JP | [2005/37] | Representative(s) | Steinecke, Peter Müller Fottner Steinecke Rechtsanwalts- und Patentanwaltspartnerschaft mbB Postfach 31 01 40 80102 München / DE | [N/P] |
| Former [2005/37] | Steinecke, Peter Müller Fottner Steinecke, P.O. Box 31 01 40 80102 München / DE | Application number, filing date | 02797400.5 | 17.12.2002 | [2005/37] | WO2002US40471 | Priority number, date | US20010341370P | 17.12.2001 Original published format: US 341370 P | [2005/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO03052121 | Date: | 26.06.2003 | Language: | EN | [2003/26] | Type: | A2 Application without search report | No.: | EP1573027 | Date: | 14.09.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.06.2003 takes the place of the publication of the European patent application. | [2005/37] | Search report(s) | International search report - published on: | US | 24.11.2005 | (Supplementary) European search report - dispatched on: | EP | 23.01.2007 | Classification | IPC: | C12Q1/44, G01N33/68 | [2006/49] | CPC: |
C12Q1/42 (EP,US);
G01N33/6893 (EP,US);
G01N2333/515 (EP,US);
G01N2333/70596 (EP,US);
G01N2500/00 (EP,US);
G01N2500/04 (EP,US)
|
| Former IPC [2006/03] | C12Q1/44 | ||
| Former IPC [2005/37] | C12Q1/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2005/37] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | Title | German: | VERFAHREN ZUR REDUZIERUNG DER ANGIOGENESE | [2005/37] | English: | METHOD OF REDUCING ANGIOGENESIS | [2005/37] | French: | PROCEDE DE REDUCTION DE L'ANGIOGENESE | [2005/37] | Entry into regional phase | 19.07.2004 | National basic fee paid | 19.07.2004 | Search fee paid | 19.07.2004 | Designation fee(s) paid | 19.07.2004 | Examination fee paid | Examination procedure | 17.06.2003 | Request for preliminary examination filed International Preliminary Examining Authority: US | 19.07.2004 | Examination requested [2005/37] | 20.04.2007 | Application deemed to be withdrawn, date of legal effect [2008/05] | 30.05.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2008/05] | Fees paid | Renewal fee | 23.12.2004 | Renewal fee patent year 03 | 27.12.2005 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.12.2006 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO0023459 (IMMUNEX CORP [US], et al) [X] 1-4 * page 3, paragraph 3 * * page 8, paragraph 2 * * page 9, paragraphs 2,3 * * claim 35 *; | [X] - GOEPFERT C ET AL, "C.Disordered Cellular Migration and Angiogenesis in cd39-Null Mice", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, (200112), vol. 104, ISSN 0009-7322, pages 3109 - 3115, XP002990752 [X] 1-7 * the whole document * DOI: http://dx.doi.org/10.1161/hc5001.100663 | [A] - PIPILI-SYNETOS E ET AL, "Evidence that platelets promote tube formation by endothelial cells on matrigel", BRITISH JOURNAL OF PHARMACOLOGY, (199811), vol. 125, no. 6, ISSN 0007-1188, pages 1252 - 1257, XP008067571 [A] 5-7 * the whole document * DOI: http://dx.doi.org/10.1038/sj.bjp.0702191 | [A] - IMAI M ET AL, "Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, (19991012), vol. 38, no. 41, ISSN 0006-2960, pages 13473 - 13479, XP002266863 [A] 1-7 * page 13473, column 2 - page 13474, column 1; table 1 * * page 13475, column 1, paragraph 3 - paragraph 5 * DOI: http://dx.doi.org/10.1021/bi990543p | [A] - CHADWICK B P ET AL, "The CD39-like Gene Family: Identification of Three New Human Members (CD39L2, CD39L3, and CD39L4), Their Murine Homologues, and a Member of the Gene Family fromDrosophila melanogaster", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, (19980615), vol. 50, no. 3, ISSN 0888-7543, pages 357 - 367, XP004449112 [A] 1-7 * the whole document * DOI: http://dx.doi.org/10.1006/geno.1998.5317 | International search | [A]WO0023459 (IMMUNEX CORP [US], et al); | [A] - GOEPFERT C. ET AL., "C.Disordered Cellular Migration and Angiogenesis in cd39-Null Mice.", CIRCULATION, (200112), vol. 104, pages 3109 - 3115, XP002990752 DOI: http://dx.doi.org/10.1161/hc5001.100663 |